- Neuro-All - University of Manitoba Mailing Lists

MNN Seminar Mar 28th @ 9am Dr. Tiina Kauppinen
by Winnipeg Chapter Society for Neuroscience 18 Mar '14

18 Mar '14

Manitoba Neuroscience Network | Seminar Series Date: Friday, March 28th, 2014 Time: 9:00 am Location: PX236/238 PsychHealth Bldg. Dr. Tiina Kauppinen Assistant Professor, Department of Pharmacology and Therapeutics Principle Investigator, Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Sciences Centre and University of Manitoba Topic: Microglial modulation as a therapeutic approach in CNS disorders. Location: PX236/238 PsychHealth Bldg. Biosketch: Tiina M Kauppinen is an Assistant Professor and principle investigator at the University of Manitoba. She obtained her Ph.D. in Biotechnology and Molecular Brain Research in 2001 from the University of Kuopio, Finland. Her Ph.D. studies (published in her maiden name, Tikka) discovered the neuroprotective potential of minocycline, an antibiotic that has several anti-inflammatory functions unrelated to its anti-microbial mechanisms. Dr. Kauppinen did her postdoctoral training at the University of California, San Francisco (2002-2006). After which she became an Adjunct Assistant Professor in the Department of Neurology at University of California, San Francisco (2006-2012). Dr. Kauppinen joined the Faculty of Medicine, University of Manitoba July 2012. Her research focuses on the role of microglia and neuroinflammation in acute (ie- stroke) and chronic (ie- Alzheimer's disease) central nervous system disorders, and on the effects of chronic inflammation on fetal (ie- gestational diabetes) and infant (ie- poor diet) neurocognitive development. The overall goals of her research program are to 1) understand how microglial functions affect neurodegeneration, neurogenesis and neuronal functions, 2) establish approaches to modulate microglial responses, and 3) develop new therapeutic strategies with multiple disease relevance. Dr. Kauppinen received a prestigious Jordi Folch Pi award 2008 from American Society for Neurochemistry. Her research has been funded by grants from American Heart and Stroke and Alzheimer Society of Canada. For more information, contact the MNN Office at (T) 235.3939 or email: mnn(a)sbrc.ca Presented in co-operation with: University of Manitoba Clinical Neuroscience An initiative of: Winnipeg Chapter Society for Neuroscience Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Reminder: Neuroscience Research Program Open House
by Kelly Jorundson 13 Mar '14

13 Mar '14

REMINDER: Tomorrow ... Friday, March 14, 2014 Everyone is invited to attend! Neuroscience Research Program - Open House WHEN: Friday, March 14, 2014 TIME: 1:00 - 3:00 pm Please stop by to see our new facility and visit with our investigators. We will provide tours, company and food. To get to us, go to the Canad Inns lobby (near Starbucks) and enter the glass doors marked "Kleysen Institute". Take the elevator to the 4th floor and go to the conference room. Location Information: Neuroscience Research Program Kleysen Institute for Advanced Medicine 4th Floor - 710 William Avenue Winnipeg, Manitoba R3E 0Z3 For more information: Chris M. Anderson, PhD Associate Professor and Director, Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Sciences Centre and University of Manitoba T: 204-318-2565 E: chris.anderson(a)med.umanitoba.ca<mailto:chris.anderson@med.umanitoba.ca> [open house.jpg] /sent on behalf of Chris M. Anderson, PhD Associate Professor and Director, Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Sciences Centre and University of Manitoba T: 204-318-2565 E: chris.anderson(a)med.umanitoba.ca<mailto:chris.anderson@med.umanitoba.ca>

1 0

Notice of seminar - Dr. Eftekharpour
by Kelly Jorundson 12 Mar '14

12 Mar '14

[cid:image001.jpg@01CF3D3E.BA91D5A0]

1 0

Seminar - Dr. Hassan Marzban Friday Mar 14 NOON
by Winnipeg Chapter Society for Neuroscience 11 Mar '14

11 Mar '14

Pharmacology and Therapeutics Seminar Series Everyone is invited! <http://www.sbrc.ca/ccarm/faculty/dr-thomas-netticadan/> Date: Friday, March 14, 2014 Time: 12:00 Noon Location: ** Pharmacology and Therapeutics Library A229 Chown Bldg.** **Video-conferenced to R1002 SBRC Hassan Marzban, <http://umanitoba.ca/faculties/medicine/units/anatomy/marzbanhassan.html > Ph.D Assistant Professor Department of Human Anatomy and Cell Science Manitoba Institute of Child Health (MICH) Faculty of Medicine, University of Manitoba Topic: "Cerebellar Development In Health and Disease; early cerebellar circuit" Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

2014 MNN Retreat - June 26-27 GIMLI, MB
by Winnipeg Chapter Society for Neuroscience 10 Mar '14

10 Mar '14

Dear Neuroscientists: As you all know, the MNN has held annual scientific meetings each of the last 4 years. The format for the meetings has been similar for each of these years and although the meetings have been well-received, we would like to introduce other formats that encourage networking and collaboration. One of these formats is a retreat-style structure that brings principal investigators together off-campus with opportunities for social interaction as well as a scientific program. This year, I have stepped aside from organizing the meeting and Paul Fernyhough will be serving as MNN meeting chair. He is looking at organizing a retreat in Gimli on June 26-27. This meeting will be for PI's only. We agree that the retreat format will likely attract fewer PI's but also that those who do attend will be focussed and enthusiastic, producing a successful event. Around 25 PI's gave a preliminary indication they would attend in response to a previous email from Paul, which I think is a strong indication that the event would succeed. Overall, the idea is that while there may be a retreat-style or alternative format meeting from time to time, there will be a traditional scientific meeting with full trainee participation at least every second year. So the plan will be to hold a more traditional style meeting again next in 2015. Thanks to Paul for taking charge. PI's can expect to receive further information from Paul. Please give him a strong idea of whether you will attend given the details he will outline. That way, he can design the best format possible. I encourage you all to participate! Sincerely, Chris Anderson President, Winnipeg Chapter, Society for Neuroscience MNN Director Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Neuroscience Research Program Open House
by Kelly Jorundson 03 Mar '14

03 Mar '14

Everyone is invited to attend! /sent on behalf of Chris M. Anderson, PhD Associate Professor and Director, Neuroscience Research Program Kleysen Institute for Advanced Medicine Health Sciences Centre and University of Manitoba T: 204-318-2565 E: chris.anderson(a)med.umanitoba.ca

1 0

Reminder - upcoming seminars next week
by Kelly Jorundson 21 Feb '14

21 Feb '14

Everyone is invited to attend! Manitoba Neuroscience Network Seminar Series Friday, February 28th, 2014 9:00 am PX236/238 PsychHealth Bldg. Dr. V. Wee Yong<http://www.ucalgary.ca/dcns/experimental/members/Yong> Professor, Canada Research Chair in Nueroimmunology Hotchkiss Brain Institute and Department of Clinical Neurosciences and Oncology University of Calgary Topic: Overcoming inhibitors in the lesion microenvironment for CNS regeneration. Biosketch: Dr. V. Wee Yong is a Professor at the Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary. He co-directs the Multiple Sclerosis (MS) Program of the Hotchkiss Brain Institute, providing the basic science leadership, and he holds the Canada Research Chair in Neuroimmunology. Dr. Yong received his Ph.D. from the University of British Columbia, Vancouver, and started his faculty appointment at the Montreal Neurological Institute, McGill University, in 1989. He located to Calgary in 1996. Dr. Yong's research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects have been guided by MS, spinal cord injury and malignant gliomas. Dr. Yong has published 230 peer-reviewed manuscripts and his research has been translated into clinical trials in MS and spinal cord injury. His work has been cited over 12,000 times by other authors in scientific publications. In 2003, Dr. Yong was awarded the Queen's Golden Jubilee Year Medallion for volunteer activities on behalf of the MS Society of Canada. In 2010, Dr. Yong was elected a fellow of the Canadian Academy of Health Sciences, a top honor for those working in the medical sciences. Dr. Yong is the immediate past chair of the Medical Advisory Committee of the MS Society of Canada, he directs the Alberta endMS Regional Research and Training Center, and he is on the editorial board of 7 international journals. In 2012, Dr. Yong was elected by an international community to be the Vice President of the International Society of Neuroimmunology; he will become its President in 2014. Brief description of research interests: Neuroimmunology is the study of inflammation in the nervous system. Virtually all neurological disorders have inflammatory components, and these include diseases traditionally associated with overt inflammation, such as multiple sclerosis (MS), and those previously thought to be purely degenerative, including Alzheimer's disease. Neuroinflammation originates from the trafficking of several leukocyte subsets into the nervous system and through the production of immune molecules by neural cells themselves. The interaction between leukocytes and neural cells further promotes neuroinflammation and injury. In recent years, reparative properties of neuroinflammation have been appreciated, so that the balance between beneficial and detrimental neuroinflammation is a crucial determinant of outcome. My research projects have been guided by 3 diseases of the central nervous system (CNS): MS, spinal cord injury (SCI) and brain tumors (malignant gliomas). MS and SCI provide my research program with diseases of chronic and acute neuroinflammation, respectively. In contrast, malignant gliomas present a disease of immunosuppression, whereby the cancer cells neutralize the activity of leukocytes that infiltrate into these tumors. My research has been translated into clinical trials in MS and in spinal cord injury. Collectively, my studies of neuroimmunology are aimed at understanding, controlling and tipping the balance of neuroinflammation towards one of neuroprotection and regeneration from CNS insults. Presented in co-operation with University of Manitoba Clinical Neuroscience Rounds ************************************** Division of Neurodegenerative Disorders, St. Boniface Hospital Research Neuroscience Seminar Series Friday, February 28th2014 12:00 Noon 500 John Buhler Research Centre - Bannatyne Campus Dr. Bruce Perkins<http://www.uhnresearch.ca/researchers/profile.php?lookup=7067> Associate Professor, Division of Endocrinology and Metabolism University of Toronto & Clinician Scientist, Lunenfeld Tanenbaum Research Institute, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital Topic: The Identification of Diabetic Neuropathy in type 1 Diabetes Biosketch: Bruce A Perkins, MD MPH is Associate Professor and Endocrinologist at the University of Toronto, and a Diabetes Complications Clinician-Scientist. He obtained his MD and Internal Medicine training at the University of Toronto, his endocrinology subspecialty training at Harvard University, his Masters of Public Health in Epidemiology at the Harvard School of Public Health, and a research fellowship in epidemiology at the Joslin Diabetes Center. In 2003 he was appointed at the Toronto General Hospital and earned a Canadian Diabetes Association early career personnel award for his work in diabetic neuropathy. His clinical practice has focused on type 1 diabetes management, and he directed the formation of an insulin pump program at the UHN. His research work has focused on clinical biomarkers for the early stages of diabetes complications using longitudinal cohort methods as well as clinical trials. Highlights are "Early GFR Loss" as a predictive marker for risk of advanced kidney disease using serial cystatin C analysis and the concept of in-vivo Corneal Confocal Microscopy as a method to analyze the small fiber morphological abnormalities that predict diabetic neuropathy. His clinical trial work in insulin pump and continuous glucose monitoring interventions has contributed to refinements in type 1 diabetes care. He is active on national and international diabetes clinical practice guideline committees including Microvascular Chair on the CDA's 2013 Clinical Practice Guidelines Steering Committee. He has received funding from the Juvenile Diabetes Research Foundation, Canadian Diabetes Association, CIHR, and the Banting and Best Diabetes Center and is a member of the JDRF's Canadian Clinical Trial Network. He is initiating a JDRF-funded nation-wide cohort study to determine factors associated with longevity in type 1 diabetes. Presented in co-operation with Manitoba Institute of Child Health Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Email: wcsn(a)sbrc.ca<mailto:wcsn@sbrc.ca> Website: www.sfn-manitoba.ca<http://www.sfn-manitoba.ca>

1 0

Rick Hansen Institute Funding: Call for Proposals
by Winnipeg Chapter Society for Neuroscience 18 Feb '14

18 Feb '14

---------------------------------- Rick Hansen Institute Call for Proposals RHI is accepting applications for funding requests pertaining to projects related to Emerging Interventions & Innovative Technologies and Preclinical SCI Research Towards Cures. Application deadline: April 30, 2014 For more information http://www.rickhanseninstitute.org/open-funding-rfa Questions contact: Phalgun Joshi, PhD Managing Director, Program Operations & Support t: 604-827-1673 e: pjoshi(a)rickhanseninstitute.org John Barclay, MBA Manager, Commercialization & Industry Relations t: 604-827-1676 e: jbarclay(a)rickhanseninstitute.org <mailto:jbarclay@rickhanseninstitute.org> Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Your input is important and appreciated
by Winnipeg Chapter Society for Neuroscience 10 Feb '14

10 Feb '14

Dear Neuroscientists, We have started to plan the Manitoba Neuroscience Network - 2014 Annual Meeting and are again looking into the possibility of holding a Retreat-style meeting mid-end of June, held over 2 days, at a site within two hours drive (e.g. Whiteshell, Kenora etc.) where a stay overnight would be encouraged (to enhance team building!). Our main focus for this year will be to feature new staff's research, with a secondary focus on promoting interests in establishing research teams (ideally linking CIHR pillars 1 and 2). Therefore, we encourage attendance from researchers in the basic and clinical realms. By at least getting pillars 1 and 2 to communicate at some point in the future we could then identify possible staff in pillars 3 and 4 at UofM (or elsewhere). And then we have the basis for competitive team grants with a strong UofM flavor. Could those that would potentially attend a retreat-style meeting in mid-end June, held over 2 days at a site ~2 hrs drive away (e.g. Whiteshell, etc), please respond ASAP so we can start planning. Regards, Paul Paul Fernyhough Program Chair - Manitoba Neuroscience Network 2014 Annual Meeting Director, Division of Neurodegenerative Disorders, St. Boniface Research Centre Professor, Departments of Pharmacology & Therapeutics, Physiology University of Manitoba Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

upcoming seminars
by Winnipeg Chapter Society for Neuroscience 04 Feb '14

04 Feb '14

Everyone is invited to attend! Manitoba Neuroscience Network Seminar Series Friday, February 28th, 2014 9:00 am PX236/238 PsychHealth Bldg. Dr. V. Wee Yong <http://www.ucalgary.ca/dcns/experimental/members/Yong> Professor, Canada Research Chair in Nueroimmunology Hotchkiss Brain Institute and Department of Clinical Neurosciences and Oncology University of Calgary Topic: Overcoming inhibitors in the lesion microenvironment for CNS regeneration. Biosketch: Dr. V. Wee Yong is a Professor at the Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary. He co-directs the Multiple Sclerosis (MS) Program of the Hotchkiss Brain Institute, providing the basic science leadership, and he holds the Canada Research Chair in Neuroimmunology. Dr. Yong received his Ph.D. from the University of British Columbia, Vancouver, and started his faculty appointment at the Montreal Neurological Institute, McGill University, in 1989. He located to Calgary in 1996. Dr. Yong's research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects have been guided by MS, spinal cord injury and malignant gliomas. Dr. Yong has published 230 peer-reviewed manuscripts and his research has been translated into clinical trials in MS and spinal cord injury. His work has been cited over 12,000 times by other authors in scientific publications. In 2003, Dr. Yong was awarded the Queen's Golden Jubilee Year Medallion for volunteer activities on behalf of the MS Society of Canada. In 2010, Dr. Yong was elected a fellow of the Canadian Academy of Health Sciences, a top honor for those working in the medical sciences. Dr. Yong is the immediate past chair of the Medical Advisory Committee of the MS Society of Canada, he directs the Alberta endMS Regional Research and Training Center, and he is on the editorial board of 7 international journals. In 2012, Dr. Yong was elected by an international community to be the Vice President of the International Society of Neuroimmunology; he will become its President in 2014. Brief description of research interests: Neuroimmunology is the study of inflammation in the nervous system. Virtually all neurological disorders have inflammatory components, and these include diseases traditionally associated with overt inflammation, such as multiple sclerosis (MS), and those previously thought to be purely degenerative, including Alzheimer's disease. Neuroinflammation originates from the trafficking of several leukocyte subsets into the nervous system and through the production of immune molecules by neural cells themselves. The interaction between leukocytes and neural cells further promotes neuroinflammation and injury. In recent years, reparative properties of neuroinflammation have been appreciated, so that the balance between beneficial and detrimental neuroinflammation is a crucial determinant of outcome. My research projects have been guided by 3 diseases of the central nervous system (CNS): MS, spinal cord injury (SCI) and brain tumors (malignant gliomas). MS and SCI provide my research program with diseases of chronic and acute neuroinflammation, respectively. In contrast, malignant gliomas present a disease of immunosuppression, whereby the cancer cells neutralize the activity of leukocytes that infiltrate into these tumors. My research has been translated into clinical trials in MS and in spinal cord injury. Collectively, my studies of neuroimmunology are aimed at understanding, controlling and tipping the balance of neuroinflammation towards one of neuroprotection and regeneration from CNS insults. Presented in co-operation with University of Manitoba Clinical Neuroscience Rounds ************************************** Division of Neurodegenerative Disorders, St. Boniface Hospital Research Neuroscience Seminar Series Friday, February 28th2014 12:00 Noon 500 John Buhler Research Centre - Bannatyne Campus Dr. Bruce Perkins <http://www.uhnresearch.ca/researchers/profile.php?lookup=7067> Associate Professor, Division of Endocrinology and Metabolism University of Toronto & Clinician Scientist, Lunenfeld Tanenbaum Research Institute, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital Topic: The Identification of Diabetic Neuropathy in type 1 Diabetes Biosketch: Bruce A Perkins, MD MPH is Associate Professor and Endocrinologist at the University of Toronto, and a Diabetes Complications Clinician-Scientist. He obtained his MD and Internal Medicine training at the University of Toronto, his endocrinology subspecialty training at Harvard University, his Masters of Public Health in Epidemiology at the Harvard School of Public Health, and a research fellowship in epidemiology at the Joslin Diabetes Center. In 2003 he was appointed at the Toronto General Hospital and earned a Canadian Diabetes Association early career personnel award for his work in diabetic neuropathy. His clinical practice has focused on type 1 diabetes management, and he directed the formation of an insulin pump program at the UHN. His research work has focused on clinical biomarkers for the early stages of diabetes complications using longitudinal cohort methods as well as clinical trials. Highlights are "Early GFR Loss" as a predictive marker for risk of advanced kidney disease using serial cystatin C analysis and the concept of in-vivo Corneal Confocal Microscopy as a method to analyze the small fiber morphological abnormalities that predict diabetic neuropathy. His clinical trial work in insulin pump and continuous glucose monitoring interventions has contributed to refinements in type 1 diabetes care. He is active on national and international diabetes clinical practice guideline committees including Microvascular Chair on the CDA's 2013 Clinical Practice Guidelines Steering Committee. He has received funding from the Juvenile Diabetes Research Foundation, Canadian Diabetes Association, CIHR, and the Banting and Best Diabetes Center and is a member of the JDRF's Canadian Clinical Trial Network. He is initiating a JDRF-funded nation-wide cohort study to determine factors associated with longevity in type 1 diabetes. Presented in co-operation with Manitoba Institute of Child Health Kelly Jorundson Administrative Manager, Division of Neurodegenerative Disorders St. Boniface Hospital Research & Department of Pharmacology & Therapeutics University of Manitoba Room R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sbrc.ca/dnd OR www.umanitoba.ca/medicine/units/pharmacology

1 0